Sarepta Therapeutics (SRPT) Retained Earnings (2010 - 2026)
Sarepta Therapeutics (SRPT) recorded quarterly Retained Earnings of -$121000.0 in Q1 2026, down 144.49% quarter-over-quarter from $272000.0 in Q4 2025, and down 455.88% on a YoY basis from $34000.0 in Q1 2025.
Sarepta Therapeutics (SRPT) Retained Earnings (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$121000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 455.88% year-over-year to -$121000.0; the TTM figure through Mar 2026 stood at -$121000.0 (down 455.88% YoY), while the FY2025 annual figure was $272000.0, up 224.77% from the prior year.
- Retained Earnings was -$121000.0 for Q1 2026 at Sarepta Therapeutics, down from $272000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $918000.0 in Q4 2023 to a low of -$4.5 billion in Q2 2025.
- Historically, Retained Earnings has averaged -$1.5 billion across 5 years, with a median of -$638000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 177162800.0% in 2022, then surged 224.77% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$3.9 billion in 2022, then soared by 100.02% to $918000.0 in 2023, then tumbled by 123.75% to -$218000.0 in 2024, then soared by 224.77% to $272000.0 in 2025, then slumped by 144.49% to -$121000.0 in 2026.
- The last three Retained Earnings figures came in at -$121000.0 (Q1 2026), $272000.0 (Q4 2025), and $220000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn | -121,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121,000.00 |
| Dec 31, 2025 | 272,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | -4.46 Bn |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | -218,000.00 |
| Sep 30, 2024 | -4.37 Bn |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -4.41 Bn |
| Dec 31, 2023 | 918,000.00 |
| Sep 30, 2023 | -638,000.00 |
| Jun 30, 2023 | -4.45 Bn |
| Mar 31, 2023 | -419,000.00 |
| Dec 31, 2022 | -3.91 Bn |
| Sep 30, 2022 | -3.21 Mn |
| Jun 30, 2022 | -3.54 Bn |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Sep 30, 2021 | -3.08 Bn |
| Jun 30, 2021 | 2,000.00 |